Navigation Links
Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
Date:1/29/2008

Pre-Clinical Studies to Commence for Neurological Diseases and Disorders

OLDSMAR, Fla., Jan. 29 /PRNewswire-FirstCall/. Cryo-Cell International Inc. (OTC Bulletin Board: CCEL) ("Cryo-Cell" or the "Company"), one of the largest and most established family cord blood banks, today announced that it has formalized a research and development agreement with Saneron CCEL Therapeutics, Inc. ("Saneron") that represents an important milestone in efforts to develop promising regenerative therapies utilizing Cryo-Cell's breakthrough C'elle(SM) (pronounced "C-L") menstrual stem cell technology. Cryo-Cell and Saneron will collaborate on research involving C'elle stem cell technology in pre-clinical models for certain neurological diseases and disorders. C'elle stem cells are derived from menstrual flow, which results from the shedding of the uterine lining (endometrium) during menstruation and contains millions of stem cells that have many properties and characteristics similar to those of both bone marrow and embryonic stem cells.

"Cryo-Cell is excited to leverage on our long relationship with Saneron, a globally recognized leader in neurological stem cell research and development, to explore utilization of C'elle menstrual stem cells in the development of potential breakthrough therapies for three very devastating disorders," stated Julie Allickson, PhD., Cryo-Cell's Vice President of Laboratory Operations and Research & Development. "We eagerly anticipate emerging research developments from Saneron related to prospective applications that may utilize the Company's novel technology and innovative proprietary service."

On November 1, 2007, Cryo-Cell announced its discovery of breakthrough menstrual stem cell technology and launched the C'elle service, the world's first-ever, exclusive service allowing women to cryopreserve their own menstrual stem cells. C'elle menstrual stem cells are adult stem cells, but they share some of the same features of embr
'/>"/>

SOURCE Cryo-Cell International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Access Pharmaceuticals Announces $2.7 Million New Equity
2. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
3. Oncolytics Biotech Inc. Announces Issuance of 8th Canadian Patent
4. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
5. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
6. 3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer
7. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
8. Arbor Surgical Technologies Announces Series C Financing and Licensing Agreement with Medtronic
9. Hoya Announces Third Quarter and Nine Month Results for 2007
10. Medefield Announces New Appointments to North American Business Unit
11. NuVasive Announces Webcast and Conference Call of Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Meet ARGUS, The World,s First Contactless Facial ... Analyze emotions and predict actions. Explore a New Generation ... Responsive-RPG: "The Eye: Genesis".      (Photo: ... https://www.youtube.com/watch?v=B1ZEtAZ2Yf8 Imagine being ... - and those of others. Being able to read ...
(Date:6/2/2015)... 2, 2015   Hospira, Inc. (NYSE: ... that its partner, Celltrion – a global biopharmaceutical company – ... Surveillance Agency in Brazil – ... for use in Brazil . The ... and sells biosimilar infliximab in 26 European countries and ...
(Date:6/2/2015)... 2, 2015   BioClinica ® , Inc., ... announced that David Peters , an accomplished senior ... President and Chief Financial Officer (CFO) and will be ... brings more than 25 years of financial and accounting ... extensive and deep knowledge in all areas of finance, ...
(Date:6/2/2015)... June 2, 2015  RXi Pharmaceuticals Corporation ... focused on discovering and developing innovative therapies ... ophthalmology, today announced that Dr. Pamela Pavco ... at the 23 rd World Congress ... will include in-depth presentations by world-class clinicians ...
Breaking Biology Technology:ARGUS - The World's First Inner Emotion Scanner Launches on KickStarter 2ARGUS - The World's First Inner Emotion Scanner Launches on KickStarter 3ANVISA Approves First Infliximab Biosimilar in Brazil 2ANVISA Approves First Infliximab Biosimilar in Brazil 3ANVISA Approves First Infliximab Biosimilar in Brazil 4ANVISA Approves First Infliximab Biosimilar in Brazil 5BioClinica Names David Peters New Chief Financial Officer 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 4
... Pain Management business, NATICK, Mass., Jan. 4 ... announced that it has completed the sale of,the ... pump,development program to former principals and shareholders of ... The sale,coincides with the closing of the amended ...
... YORK, Jan. 4 QED International,Associates, Inc., administrator ... indexes for the HealthShares(TM) Exchange-Traded Funds,today announced that ... January,7, 2008, Maxygen, Inc. (Nasdaq: MAXY ) ... in the HealthShares(TM) Autoimmune-Inflammation Index.,Alpharma, Inc. (NYSE: ...
... ARLINGTON, Va., Jan. 4 Faced with ... suppliers are turning their attention to,opportunities in ... navigate these unfamiliar waters, leading research and,advisory ... report,examining the marketing and media preferences of ...
Cached Biology Technology:Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program 2Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program 3QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes 2Study Examines Media Preferences of Life Scientists in Applied Markets 2Study Examines Media Preferences of Life Scientists in Applied Markets 3
(Date:6/1/2015)... -- According to a new market ... (Government, Military & Defense, Healthcare, Banking & Finance, ... (Face Recognition, Fingerprint Recognition, Iris Recognition, Palm Recognition, ... Function (Contact and Non-Contact) & Geography ( ... , APAC, Row) - Global Forecast to 2020", ...
(Date:5/27/2015)... CLEVELAND , May 27, 2015 /PRNewswire/ ... in medication safety systems and image documentation ... provider of comprehensive, technologically-advanced automation solutions, is ... art integration. The Codonics® Safe Label System® ... used in conjunction with the Omnicell Anesthesia ...
(Date:5/22/2015)... CT , May 22, 2015  NXT-ID, Inc. (NASDAQ: ... June 1st, it will be ending its promotional pricing and ... . Laurence Savin , Head of Marketing ... exclusive promotional pricing until the end of May. To get ... wocketwallet.com/invite and when we open the store on June 1, ...
Breaking Biology News(10 mins):Next Generation Biometrics Market Worth $24,448.84 Million by 2020 2Next Generation Biometrics Market Worth $24,448.84 Million by 2020 3Next Generation Biometrics Market Worth $24,448.84 Million by 2020 4Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3
... economy of the cell, little bubbles called vesicles serve ... port - the cell membrane. Some of these vesicles, ... protein factory. Scientists have long believed that other, ... and proteins through an independent process. By using a ...
... A revolutionary new protein stabilisation technique has been ... Sciences Research Council (BBSRC) which could lead to 30 ... for drug development - opening up exciting possibilities in ... a vital first step in developing new drugs, but ...
... and China have gathered in Barcelona this week to report ... data from ESA and Chinese Earth observation satellites. Dragon ... of Science and Technology (MOST) of China encourages scientists ... environmental phenomena in China. ,The symposium, held in Barcelona,s World ...
Cached Biology News:Cells use import machinery to export their goods as well 2Cells use import machinery to export their goods as well 3New nanoparticles could revolutionize therapeutic drug discovery 2Europe and China watching Earth together 2
Request Info...
Penicillin-Streptomycin liquid...
...
The BD OptEIA Rat TNF-alpha ELISA Kit is for the quantitative determination of TNF-alpha in rat serum, plasma and cell culture supernatant....
Biology Products: